Attorney General Miyares Announces $150 Million Multistate Settlement with Hikma Pharmaceuticals 

~ Virginia is expected to receive approximately $2.16 million ~  

RICHMOND, Va. – Attorney General Jason Miyares announced today a $150 million multistate settlement in principle with opioid manufacturer Hikma Pharmaceuticals (Hikma) for its role in fueling the opioid crisis. Hikma produces a range of branded and generic opioid products and sells hundreds of millions of opioid doses every year. From 2006 to 2021, Hikma failed to monitor and report suspicious opioid orders from potentially illegal distributors, even while its personnel knew their systems to monitor suspicious orders were inadequate and prone to failure. 

The settlement will provide $115 million in cash and $35 million in opioid addiction treatment medication to resolve claims brought by states and local communities against Hikma. States that do not accept the medication will receive cash in lieu of product. Virginia is expected to receive approximately $2.16 million. 

“It’s impossible to put a price on the devastation that opioid addiction has caused Virginians. But by holding opioid manufacturers accountable for their role in this epidemic, my office is able to support rehabilitation treatment and education for struggling Virginia communities,” said Attorney General Miyares. 

The settlement in principle was negotiated by the attorneys general of New York, California, Delaware, Tennessee, Utah, and Virginia in coordination with an executive committee consisting of the attorneys general of Colorado, Idaho, Illinois, Massachusetts, North Carolina, Ohio, and Oregon.  

###